Lenda-Petrykowska, M.; Sulżyc-Bielicka, V.; Dobrzycki, W.; Safranow, K.; Świtała, J.; Kostrzewa-Nowak, D.; Bielicki, P.
Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma. Cancers 2025, 17, 3267.
https://doi.org/10.3390/cancers17193267
AMA Style
Lenda-Petrykowska M, Sulżyc-Bielicka V, Dobrzycki W, Safranow K, Świtała J, Kostrzewa-Nowak D, Bielicki P.
Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma. Cancers. 2025; 17(19):3267.
https://doi.org/10.3390/cancers17193267
Chicago/Turabian Style
Lenda-Petrykowska, Marzena, Violetta Sulżyc-Bielicka, Wojciech Dobrzycki, Krzysztof Safranow, Jerzy Świtała, Dorota Kostrzewa-Nowak, and Paweł Bielicki.
2025. "Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma" Cancers 17, no. 19: 3267.
https://doi.org/10.3390/cancers17193267
APA Style
Lenda-Petrykowska, M., Sulżyc-Bielicka, V., Dobrzycki, W., Safranow, K., Świtała, J., Kostrzewa-Nowak, D., & Bielicki, P.
(2025). Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma. Cancers, 17(19), 3267.
https://doi.org/10.3390/cancers17193267
